NewsBusiness BrainStorm Cell Therapeutics regains compliance with Nasdaq (NASDAQ:BCLI) October 30, 2024 0 Facebook Twitter Pinterest WhatsApp ReddIt BrainStorm Cell Therapeutics regains compliance with Nasdaq Clover Health regains compliance with Nasdaq minimum bid price requirementDateJune 27, 2024In relation toBusinessLa Rosa regains compliance with Nasdaq listing rules (NASDAQ:LRHC)DateApril 19, 2024In relation toBusinessAditx Therapeutics announces 1-for-40 reverse stock split for Nasdaq complianceDateSeptember 27, 2024In relation toBusiness
